Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4<sup>th</sup> Edition of the Chinese National Guidelines for the Initial-Stage Management of COVID-19 via Molecular Docking

<div>The simulation model of SARS-CoV spike glycoprotein and angiotensin-converting enzyme 2.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4<sup>th</sup> Edition of the Chinese National Guidelines for the Initial-Stage Management of COVID-19 via Molecular Docking 

Figure 2 | Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4th Edition of the Chinese National Guidelines for the Initial-Stage Management of COVID-19 via Molecular Docking 